BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• BioMidwest

  World Health Organization Announces Levacor VAD Could Avoid Key Problem Associated With Current VAD Treatment

  December 6, 2010

   · 

  4 min read
• Biotech Beach

  FDA Advisory Committee Recommends Approval to Expand Use of Allergan Inc.'s Lap-Band for Obese Adults

  December 6, 2010

   · 

  8 min read
• FDA Receives Alcon, Inc. Clearance To Implement Corrective Action Plan to Correct Malfunctions For Constellation Vision System

  December 6, 2010

   · 

  1 min read
• Drug Development

  Geron Corporation Presents Clinical Data on Its Telomerase Vaccine at the 2010 American Society of Hematology Meeting

  December 6, 2010

   · 

  1 min read
• Drug Development

  Baxter International, Inc. Presents Interim Phase 1 Safety and Tolerability Data at American Society of Hematology Meeting for Its Investigational Treatment for von Willebrand Disease

  December 6, 2010

   · 

  1 min read
• Biotech Bay

  ChemGenex Pharmaceuticals Limited Presents Updated Analysis at American Society of Hematology on OMAPRO(TM) in CML Patients Who Failed Two or Three Approved TKI Drugs

  December 6, 2010

   · 

  1 min read
• Business

  Forest Laboratories, Inc. and Gruenenthal Enter Into Licensing Agreement for the Development and Commercialization of Novel Analgesic Compound

  December 6, 2010

   · 

  1 min read
• Deals

  Acquisition of GTC Biotherapeutics by LFB Biotechnologies Completed

  December 6, 2010

   · 

  1 min read
• Drug Development

  Long-Term Follow-Up Data from Phase 2 Study Show Micromet’s Blinatumomab Produces Durable Remissions in Patients with Acute Lymphoblastic Leukemia

  December 6, 2010

   · 

  1 min read
• Drug Development

  UCB Group: Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) C-V Effectively Reduced Partial-Onset Seizure Frequency and Improved Health-related Quality of Life

  December 6, 2010

   · 

  14 min read